美股市場個股詳情
ARTV Artiva Biotherapeutics
- 11.000
- -0.300-2.65%
收盤價 08/08 16:00 (美東)
2.56億總市值-9865市盈率TTM
11.205最高價10.890最低價9.73萬股成交量11.190今開11.300昨收107.09萬成交額0.70%換手率虧損市盈率(靜)2328.16萬總股本16.00052周最高-1.47市淨率1.53億流通值10.80052周最低--股息TTM1392.00萬流通股16.000歷史最高--股息率TTM2.79%振幅10.800歷史最低11.009平均價1股每手
關於Artiva Biotherapeutics公司
Artiva Biotherapeutics Inc 是一家生物製藥公司。該公司致力於推進現成的、同種異體NK細胞療法的管道，用於治療血液惡性腫瘤或實體腫瘤。該公司的管道項目包括Artiva-Funded Trials和Collaborator-Funded Trials。
公司介紹
公司代碼ARTV
公司名稱Artiva Biotherapeutics
上市日期2024/07/19
發行價格12.00
成立日期2019
CEODr. Fred Aslan, M.D.
所屬市場納斯達克
員工數量81
證券類型海外普通股
年結日12-31
公司地址5505 Morehouse Drive,Suite 100
城市San Diego
省份加利福尼亞州
國家美國
郵編92121
電話1-858-267-4467
董事高管
- 姓名
- 職務
- 年薪
- Dr. Fred Aslan, M.D.
- President, Chief Executive Officer and Director
- 110.78萬
- Neha Krishnamohan
- Executive Vice President, Corporate Development, Chief Financial Officer and Principal Accounting Officer
- --
- Christopher Horan
- Chief Technical Operations Officer
- 72.69萬
- Thorsten Graef, M.D.,PhD
- Chief Medical Officer
- --
- Jennifer Kinsbruner Bush
- Chief Operating Officer, Chief Legal Officer, Corporate Secretary and Compliance Officer
- 72.58萬
- Dr. Heather Raymon, PhD
- Senior Vice President, Research and Early Development
- --
- Dr. Brian Daniels,M.D.
- Chairman of the Board
- --
- Dr. Diego Miralles, M.D.
- Director
- --
- Yong-Jun Huh
- Director
- --
- James Jong-eun Park
- Director
- --
- Elizabeth L. Hougen
- Independent Director
- --
- Dr. Yvonne Yamanaka, PhD
- Independent Director
- --
- Dr. Laura Bessen, M.D.
- Independent Director
- --
- Dr. Laura Stoppel, PhD
- Independent Director
- --
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
